Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...

One particular metabolite, AMK, has shown great potential in improving memory and safeguarding against cognitive ...

A study examining the effects of virtual reality cognitive training on Chinese adolescents with mild to moderate depression ...

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Xanomeline/trospium chloride may help improve cognition in patients with acute schizophrenia and cognitive impairment, ...

A recent study led by researchers at the University of Southern California (USC) has uncovered a connection between mild ...

Predicted ages for the onset of mild cognitive impairment and Alzheimer’s dementia ... the researchers employed data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer (A4) study to ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...